Aleman, A., Dutta, R. P., Oekelen, O. V., Melnekoff, D., Mouhieddine, T., Grossman, L., Reci, S., Desai, S., Brunner, P., Laganà, A., Jagannath, S., Brody, J., Parekh, S. (2025). Genomic alterations in TET2 and EZH2 serve as critical drivers of clonal malignant evolution in anti-BCMA CAR-T therapy for multiple myeloma.. Blood. https://doi.org/10.1182/blood-2025-3946